Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches
-
Published:2023-01
Issue:
Volume:179
Page:48-55
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Roggia CristianaORCID, Armeanu-Ebinger Sorin, Gschwind Axel, Seibel-Kelemen Olga, Hertler Sonja, Faust Ulrike, Liebmann AlexandraORCID, Haack Tobias B., Neumann ManuelaORCID, Bonzheim Irina, Forschner Andrea, Kopp Hans-Georg, Herster Franziska, Hartkopf AndreasORCID, Bitzer Michael, Malek Nisar P., Brecht Ines B., Ruhm Kristina, Möller Yvonne, Löwenheim Hubert, Ossowski StephanORCID, Rieß Olaf H., Schroeder Christopher
Subject
Cancer Research,Oncology
Reference35 articles.
1. Global implementation of precision oncology;Yam;JCO Precis Oncol,2021 2. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients;Zehir;Nat Med,2017 3. Initiative for molecular profiling and advanced cancer therapy (IMPACT): an MD Anderson precision medicine study;Tsimberidou;JCO Precis Oncol,2017 4. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors;Fiala;Nat Cancer,2021 5. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Le Tourneau;Lancet Oncol,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|